Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
about
Controversies in the Mechanism of Total Parenteral Nutrition Induced PathologyA metabolomic analysis of two intravenous lipid emulsions in a murine modelFish Oil Lipid Emulsion-Associated Sea-Blue Histiocyte Syndrome in a Pediatric Patient.Innovative parenteral and enteral nutrition therapy for intestinal failure.Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease.The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy.Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oilParenteral nutrition-associated liver injury and increased GRP94 expression prevented by ω-3 fish oil-based lipid emulsion supplementation.The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice.Parenteral nutrition supplementation in biliary atresia patients listed for liver transplantation.Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease.The relationship between the parenteral dose of fish oil supplementation and the variation of liver function tests in hospitalized adult patientsLow-Dose Intravenous Soybean Oil Emulsion for Prevention of Cholestasis in Preterm Neonates.Kinetics of phytosterol metabolism in neonates receiving parenteral nutritionIntravenous Lipid Emulsions in Parenteral NutritionDocosahexaenoic acid and arachidonic acid prevent essential fatty acid deficiency and hepatic steatosis.Steroidal compounds in commercial parenteral lipid emulsions.A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial.Short bowel syndrome results in increased gene expression associated with proliferation, inflammation, bile acid synthesis and immune system activation: RNA sequencing a zebrafish SBS modelLow-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders.The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).Short-term intravenous fish oil and pediatric intestinal failure associated liver disease: 3-year follow-up on liver function and nutrition.Necrotizing Enterocolitis and Central Line Associated Blood Stream Infection Are Predictors of Growth Outcomes in Infants with Short Bowel Syndrome.The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model.Daily Enteral DHA Supplementation Alleviates Deficiency in Premature InfantsSkeletal integrity and visceral transplantationNecrotizing enterocolitis is associated with earlier achievement of enteral autonomy in children with short bowel syndrome.Neurodevelopmental and Cognitive Outcomes in Children With Intestinal Failure.[13C]Methionine breath test to assess intestinal failure-associated liver disease.The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants.Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators.Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: an ongoing positive experience.Short bowel syndrome in the NICUUse of Fish Oil-Based Lipid Emulsions in Infants With Intestinal Failure-Associated Liver Disease: A Case Series.New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs.Omega-3 long chain polyunsaturated Fatty acids for treatment of parenteral nutrition-associated liver disease: a review of the literatureImpact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.Liver disease secondary to intestinal failure.Preservation of biochemical liver function with low-dose soy-based lipids in children with intestinal failure-associated liver disease.
P2860
Q26865276-F56A24C9-7E12-44D3-A50C-EAA7E2664D75Q28485918-BE62AE4B-13C7-48AA-B73A-AA9C93A2BE0BQ33424368-57027A15-6B0D-446D-99D3-E2893539E773Q33641177-A6A1EFE9-0374-413F-9725-FA5709525F2EQ33805839-CC9D2168-0765-4BDA-96B3-439FE8DA0530Q33813004-634F792F-6379-4076-8950-B7F303C4F117Q34624462-4F4190EC-AE59-47D2-986E-819AA18E715AQ34631697-F3F3AF53-13FB-45FC-8050-A6FA1067F9C9Q34778491-62E7D615-C735-45A4-B9D9-49B115E492EDQ35631885-69E8A029-65CA-4B5B-8DF3-8C503EA201BFQ35679248-21460240-2982-4C7A-8CFF-6733C03B9AE4Q35809593-9B43D0FD-7E58-48C0-B81B-10F8E8DECE21Q35956445-D3F10677-3FBE-47E0-97F3-F18C90ED3C05Q35988336-F14422F8-09FF-43CA-A84B-FD3950CB7C81Q36033721-078E0A52-7DE3-43AA-B087-D55347FEFA26Q36049319-A1FBE997-96AA-4152-861E-50946B803E54Q36250280-E26414A9-B750-4062-8D17-31F980405F06Q36254936-7BF88605-F51B-47E6-8774-04A2BB7778A9Q36259027-DF2A1AEE-C0D4-4299-BEFC-D25543DBBBF9Q36328532-73D3E770-4C3B-43DF-973F-93D7BADB9F7EQ36538113-1936BE18-D539-4770-95D7-66C743300674Q36557747-E0A188F4-60B5-4CF8-AD9C-C6C895B6A42CQ36693018-71E36C37-FF15-4CCD-96B2-36FA4A826229Q36717962-F896FC8A-AD82-46E9-9C7C-DC4AD76D24F9Q36759050-5B8A40FD-E3E3-4766-8544-40C7D3FF9B10Q36908631-0263A078-C770-4CDC-AEF3-F0954AA4ADA3Q36930846-E5B8E71B-17D6-4A86-B98B-6D8F7315E181Q36994107-B453BDF5-8357-4596-ACE7-20DFFDB05DE3Q37041293-787728B9-C7F8-4A08-9F92-F96536A4A5E4Q37274324-3D965EE2-1E6E-42E2-8F50-F3115848C31EQ37296480-B34B0F3C-5BE0-4F3F-9BE7-7C901835C277Q37440091-2E504CCB-8386-4E22-8D9A-33D093052004Q37446645-B280D4BC-E39F-4BD7-B13B-CC8FBF2F6B79Q37455400-10B98A9C-A86B-4C53-87F8-38134022ABC0Q37576936-B8293096-CEC6-40C5-B9CF-98DDEC18303DQ37603224-A1481768-9623-4DA7-949F-DBC2282FAE4CQ38000190-7841A00C-130B-4448-88E6-80401775915BQ38178585-E71B244D-A247-4C2A-9B9C-A699A95D32A1Q38189410-9E7600E5-8E1C-4D0D-B84B-E4310FB32E4EQ38365111-34FEE5C1-2D58-4C73-92F5-0EA2D57D6114
P2860
Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Parenteral fish oil improves o ...... ition-associated liver injury.
@ast
Parenteral fish oil improves o ...... ition-associated liver injury.
@en
type
label
Parenteral fish oil improves o ...... ition-associated liver injury.
@ast
Parenteral fish oil improves o ...... ition-associated liver injury.
@en
prefLabel
Parenteral fish oil improves o ...... ition-associated liver injury.
@ast
Parenteral fish oil improves o ...... ition-associated liver injury.
@en
P2093
P2860
P1433
P1476
Parenteral fish oil improves o ...... rition-associated liver injury
@en
P2093
Christopher Duggan
Clarissa Valim
Elizabeth M Robinson
Jonathan A Meisel
Kathleen M Gura
Mark Puder
P2860
P304
P356
10.1097/SLA.0B013E3181B36657
P407
P577
2009-09-01T00:00:00Z